Jon Reynolds
Co-Founder @ SwiftKey
London, United Kingdom
Jon Reynolds is a Series A investor at SwiftKey in London focused on FinTech and Medical. Jon Reynolds is the Co-Founder and CEO at SwiftKey. He attended University of Cambridge during 2004 - 2007.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Jon Reynolds invests in
Stages Jon Reynolds invests in
Countries Jon Reynolds invests in
Round sizes
Round size
- Series A
- $8.3M–$8.9M
Investment Focus
Industry
- FinTech 1 (20%)
- Medical 1 (20%)
- Database 1 (20%)
- Internet 1 (20%)
- Software 1 (20%)
Stage
- Series A 2 (40%)
- Seed 1 (20%)
- Series C 1 (20%)
- Venture - Series Unknown 1 (20%)
Country
- United Kingdom 3 (60%)
- United States 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Provenance
|
The trusted data layer for agentic commerce. Provenance powers enriched product attributes for 300+ brands and retailers, including L’Oreal, Holland & Barrett, THG, Nestle, Unilever, LVMH, Diageo and Ocado, positioning it as a trusted infrastructure layer for AI discovery and values-driven commerce.With AI-driven commerce projected to reach$3–5 trillion by 2030, brands and retailers face a structural challenge: product claims are largely unstructured, unverifiable and lacking trust signals for AI systems. Provenance converts complex product data - certifications, sustainability, health and efficacy claims - into verified, machine-readable claims that AI systems can reliably interpret and cite, building on over a decade of domain expertise in the integrity, validation and compliance of CPG product claims. | $5.4M / Venture - Series Unknown / Mar 07, 2022 | |
Onfido, an Entrust company
|
Onfido digitally proves a user’s real identity using AI technology, by verifying their photo ID and comparing it to their facial biometrics. It means users and businesses can verify their online identities anywhere and anytime, without compromising on experience, inclusion, privacy or security. Onfido powers over 1,500 fintech, banking, andmarketplace clients globally—helping them onboard more users while reducing risk. Identity underpins all transactions, and over the coming years, access to everything will be based on every user's ability to easily and securely prove their legal identity. This will change how we think of access—everything from opening a bank account to self-checking-in to a hotel, and ultimately voting. | $24.2M / Series C / Sep 27, 2017 | |
Hinge Health
|
Hinge Health is pioneering the world’s most patient-centered Digital Musculoskeletal (MSK) Clinic™. Four in five employers and 90% of health plans with a digital MSK solution have chosen Hinge Health. Hinge Health reduces MSK pain, surgeries, and opiate use by pairing advanced wearable sensors and computer vision technology with a comprehensiveClinical Care Team of physical therapists, physicians, board-certified health coaches, and more. Hinge Health’s HingeConnect integrates with 750,000+ in-person providers and enables real-time interventions for elective MSK surgeries, driving proven medical claims reduction. Available to over 12 million members, Hinge Health is the #1 Digital MSK Clinic with more than 500 employer and health plan customers, including Boeing, Salesforce, and US Foods. Learn more at http://www.hingehealth.com. | $8.3M / Series A / Jul 24, 2017 | |
Farmdrop
|
Farmdrop is the online ethical supermarket delivering locally procuded, organic groceries and ethical home essentials directly to your door. It brings tastier, healthier and more convenient food, all while supporting a more sustainable food system for everyone.By cutting out the middleman, Farmdrop pays a fairer price to producers, whilecustomers get access to food which is up to five times fresher than what is sold by conventional supermarkets. Because your shop shouldn't cost the Earth. | $8.9M / Series A / Apr 23, 2017 | |
|
Hinge Health
|
Hinge Health is pioneering the world’s most patient-centered Digital Musculoskeletal (MSK) Clinic™. Four in five employers and 90% of health plans with a digital MSK solution have chosen Hinge Health. Hinge Health reduces MSK pain, surgeries, and opiate use by pairing advanced wearable sensors and computer vision technology with a comprehensiveClinical Care Team of physical therapists, physicians, board-certified health coaches, and more. Hinge Health’s HingeConnect integrates with 750,000+ in-person providers and enables real-time interventions for elective MSK surgeries, driving proven medical claims reduction. Available to over 12 million members, Hinge Health is the #1 Digital MSK Clinic with more than 500 employer and health plan customers, including Boeing, Salesforce, and US Foods. Learn more at http://www.hingehealth.com. | $1.3M / Seed / Jun 20, 2016 |
Co-Investors
About SwiftKey
SwiftKey is a technology company that aims to enhance interaction between keyboards and people. It upgrades smartphone keyboards to make typing faster, by utilizing artificial intelligence to learn from each user in order to autocorrect and predict their next word. The SwiftKey Keyboard for Android supports more than 80 languages.SwiftKey wasfounded by Ben Medlock and Jon Reynolds in 2008 and is based in London, United Kingdom.
SwiftKey Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Jon Reynolds
Co-Founder
|
|||
Ben Medlock
Co-founder
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Jon Reynolds invest in?
Jon Reynolds invests primarily in FinTech, Medical and Database startups, most often at Series A and Seed stage. Most of the 5 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Jon Reynolds's check size?
Jon Reynolds typically joins rounds of $8.3M–$8.9M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Jon Reynolds participates in.
When did Jon Reynolds last invest?
The most recent investment recorded for Jon Reynolds closed in Mar 2022. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
